Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen

NCT04659512 is registered in ClinicalTrials.gov with St. Erik Eye Hospital as lead sponsor.

NCT NCT04659512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen
Lead sponsor
St. Erik Eye Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
June 6, 2020
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration